Moreover, Ma et al. [24] identified maternal KIR2DL4–fetal HLA-G genotype combinations that modulate preeclampsia risk, underscoring the genetic dimension of immune tolerance. The gene discussed is KIR2DL4; the disease is preeclampsia.